BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 36968111)

  • 1. Replication in the presence of dengue convalescent serum impacts Zika virus neutralization sensitivity and fitness.
    Marano JM; Weger-Lucarelli J
    Front Cell Infect Microbiol; 2023; 13():1130749. PubMed ID: 36968111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity.
    Regla-Nava JA; Wang YT; Fontes-Garfias CR; Liu Y; Syed T; Susantono M; Gonzalez A; Viramontes KM; Verma SK; Kim K; Landeras-Bueno S; Huang CT; Prigozhin DM; Gleeson JG; Terskikh AV; Shi PY; Shresta S
    Cell Rep; 2022 Apr; 39(2):110655. PubMed ID: 35417697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.
    Priyamvada L; Quicke KM; Hudson WH; Onlamoon N; Sewatanon J; Edupuganti S; Pattanapanyasat K; Chokephaibulkit K; Mulligan MJ; Wilson PC; Ahmed R; Suthar MS; Wrammert J
    Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7852-7. PubMed ID: 27354515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.
    Singh T; Miller IG; Venkatayogi S; Webster H; Heimsath HJ; Eudailey JA; Dudley DM; Kumar A; Mangan RJ; Thein A; Aliota MT; Newman CM; Mohns MS; Breitbach ME; Berry M; Friedrich TC; Wiehe K; O'Connor DH; Permar SR
    mBio; 2024 Mar; 15(3):e0316023. PubMed ID: 38349142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
    Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
    J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions.
    Chen GH; Dai YC; Hsieh SC; Tsai JJ; Sy AK; Jiz M; Pedroso C; Brites C; Netto EM; Kanki PJ; Saunders DRD; Vanlandingham DL; Higgs S; Huang YS; Wang WK
    Emerg Microbes Infect; 2024 Dec; 13(1):2301666. PubMed ID: 38163752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
    Lin DC; Weng SC; Tsao PN; Chu JJH; Shiao SH
    Parasit Vectors; 2023 May; 16(1):160. PubMed ID: 37165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection, dissemination, and transmission efficiencies of Zika virus in Aedes aegypti after serial passage in mosquito or mammalian cell lines or alternating passage in both cell types.
    Talavera-Aguilar LG; Murrieta RA; Kiem S; Cetina-Trejo RC; Baak-Baak CM; Ebel GD; Blitvich BJ; Machain-Williams C
    Parasit Vectors; 2021 May; 14(1):261. PubMed ID: 34006306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
    Contreras M; Stuart JB; Levoir LM; Belmont L; Goo L
    mBio; 2024 Feb; 15(2):e0304823. PubMed ID: 38193697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Degrees of 5'-to-3' DAR Interactions Modulate Zika Virus Genome Cyclization and Host-Specific Replication.
    Li XD; Deng CL; Yuan ZM; Ye HQ; Zhang B
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.
    Salgado BB; Maués FCJ; Jordão M; Pereira RL; Toledo-Teixeira DA; Parise PL; Granja F; Souza HFS; Yamamoto MM; Chiang JO; Martins LC; Boscardin SB; Lalwani JDB; Vasconcelos PFC; Proença-Modena JL; Lalwani P
    Int J Infect Dis; 2023 Apr; 129():142-151. PubMed ID: 36736575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term.
    Katzelnick LC; Zambrana JV; Elizondo D; Collado D; Garcia N; Arguello S; Mercado JC; Miranda T; Ampie O; Mercado BL; Narvaez C; Gresh L; Binder RA; Ojeda S; Sanchez N; Plazaola M; Latta K; Schiller A; Coloma J; Carrillo FB; Narvaez F; Halloran ME; Gordon A; Kuan G; Balmaseda A; Harris E
    Sci Transl Med; 2021 Oct; 13(614):eabg9478. PubMed ID: 34613812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
    Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Circulation of All Four Dengue Viruses and Zika Virus in Guerrero, Mexico, 2019.
    Nunez-Avellaneda D; Tangudu C; Barrios-Palacios J; Machain-Williams C; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Nunez-Avellaneda S; McKeen LA; Canche-Aguilar I; Loaeza-Díaz L; Blitvich BJ
    Vector Borne Zoonotic Dis; 2021 Jun; 21(6):458-465. PubMed ID: 33944623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
    Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
    Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cross-reactivity among flaviviruses using sera of patients with dengue showed the importance of neutralization tests with paired serum samples for the correct interpretations of serological test results for dengue.
    Maeki T; Tajima S; Ando N; Wakimoto Y; Hayakawa K; Kutsuna S; Kato F; Taniguchi S; Nakayama E; Lim CK; Saijo M
    J Infect Chemother; 2023 May; 29(5):469-474. PubMed ID: 36702208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.